Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Quarterly results
Appointed director
CC transcript
|
|
PLUS THERAPEUTICS, INC. (CYTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 1.9% stake in Plus Therapeutics, Inc. |
| 02/04/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/26/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/26/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/29/2021 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.9% stake in Plus Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| Anson Funds Management LP reports a 4.9% stake in Plus Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| Sassicaia Capital Advisers LLC reports a |
| 02/11/2020 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in Plus Therapeutics, Inc. |
| 08/28/2018 |
SC 13G/A
| Swissquote Bank SA reports a 4.9% stake in Cytori Therapeutics, Inc. |
| 05/24/2018 |
SC 13G/A
| PostFinance AG reports a 4.5% stake in Cytori Therapeutics, Inc. |
| 04/10/2018 |
SC 13G/A
| PostFinance AG reports a 5.9% stake in Cytori Therapeutics, Inc. |
| 01/04/2018 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 2.9% stake in Cytori Therapeutics, Inc. |
| 01/04/2018 |
SC 13G/A
| Azaya Therapeutics Inc has filed a Schedule 13D for Cytori Therapeutics, Inc. |
| 01/06/2017 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 8.1% stake in Cytori Therapeutics, Inc. |
| 02/12/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2016 |
SC 13G/A
| CVI Investments, Inc. reports a 2.3% stake in Cytori Therapeutics, Inc. |
| 02/13/2012 |
SC 13G/A
| CYTORI THERAPEUTICS, INC. reports a 5.8% stake in CYTORI THERAPEUTICS INC |
| 02/14/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/12/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/12/2010 |
SC 13G/A
| CYTORI THERAPEUTICS, INC. reports a 3.4% stake in Cytori Therapeutics, Inc. |
| 02/13/2008 |
SC 13G/A
| GAGNON NEIL reports a 12.2% stake in CYTORI THERAPEUTICS, INC. |
| 01/11/2008 |
SC 13G/A
| MEDTRONIC INC reports a 0% stake in Cytori Therapeutics, Inc. |
| 02/08/2006 |
SC 13G/A
| GAGNON NEIL reports a 13.4% stake in 1 Cytori Therapeutics, Inc. |
| 03/07/2005 |
SC 13G/A
| DEERFIELD CAPITAL LP reports a 0% stake in Macropore Biosurgery, Inc. |
| 03/04/2005 |
SC 13G/A
| GAGNON NEIL reports a 11.3% stake in 1 MacroPore Biosurgery, Inc. |
| 02/02/2005 |
SC 13G/A
| DEERFIELD CAPITAL LP reports a 9.6% stake in Macropore Biosurgery, Inc. |
|
|